MedTrace Logo

A Setting Focus Overdose Prevention Intervention

NCT05320835 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 285

Last updated 2026-05-22

No results posted yet for this study

Summary

A pilot injection-setting targeted peer-driven intervention to reduce HIV and hepatitis C virus transmission and overdose risk behaviors among people who inject drugs (PWID).

Conditions

  • HIV Infections
  • HCV
  • Drug Overdose

Interventions

BEHAVIORAL

HIV, HCV and overdose prevention

HIV, HCV and overdose prevention

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Johns Hopkins Bloomberg School of Public Health

    lead OTHER

Principal Investigators

  • Carl Latkin, PhD · Johns Hopkins Bloomberg School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-30
Primary Completion
2026-12-01
Completion
2027-05-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05320835 on ClinicalTrials.gov